BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 21612697)

  • 1. [Clinical features on chromophobe renal cell carcinoma].
    Wang ZH; DU LH; Hu ZQ; Chen XG; Zhao X; Wang SG; Zhuang QY; Ye ZQ
    Zhonghua Wai Ke Za Zhi; 2011 Apr; 49(4):320-3. PubMed ID: 21612697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Chromophobe renal cell carcinoma: a clinicopathological study of 16 cases].
    Nakaigawa N; Yao M; Kondo K; Kishida T; Noguchi K; Kubota Y; Nagashima Y; Kawano N; Inayama Y; Nozawa A
    Hinyokika Kiyo; 2006 Jan; 52(1):1-6. PubMed ID: 16479980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of pNx/pN0 grouping in a multivariate setting for outcome modeling in patients with clear cell renal cell carcinoma.
    Ward JF; Blute ML; Cheville JC; Lohse CM; Weaver AL; Zincke H
    J Urol; 2002 Jul; 168(1):56-60. PubMed ID: 12050492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series.
    Volpe A; Novara G; Antonelli A; Bertini R; Billia M; Carmignani G; Cunico SC; Longo N; Martignoni G; Minervini A; Mirone V; Simonato A; Terrone C; Zattoni F; Ficarra V; ;
    BJU Int; 2012 Jul; 110(1):76-83. PubMed ID: 22044519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small renal tumors: correlation of clinical and pathological features with tumor size.
    Pahernik S; Ziegler S; Roos F; Melchior SW; Thüroff JW
    J Urol; 2007 Aug; 178(2):414-7; discussion 416-7. PubMed ID: 17561161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Analysis of clinicopathological features and prognosis in 68 patients with chromophobe renal cell carcinoma].
    Huang JW; Zhang J; Dong BJ; Kong W; Niu SX; Chen YH; Xue W; Liu DM; Huang YR
    Zhonghua Zhong Liu Za Zhi; 2012 Jul; 34(7):510-3. PubMed ID: 22967469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nephron sparing surgery for central renal tumors: experience with 33 cases.
    Black P; Filipas D; Fichtner J; Hohenfellner R; Thüroff JW
    J Urol; 2000 Mar; 163(3):737-43. PubMed ID: 10687967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome of isolated renal cell carcinoma fossa recurrence after nephrectomy.
    Itano NB; Blute ML; Spotts B; Zincke H
    J Urol; 2000 Aug; 164(2):322-5. PubMed ID: 10893575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term survival of patients with unilateral sporadic multifocal renal cell carcinoma according to histologic subtype compared with patients with solitary tumors after radical nephrectomy.
    Dimarco DS; Lohse CM; Zincke H; Cheville JC; Blute ML
    Urology; 2004 Sep; 64(3):462-7. PubMed ID: 15351571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Nephron-sparing surgery for small renal cell carcinoma: clinical analysis of 21 cases].
    Xiao YJ; Zheng SB; Tan WL; Chen T; Qi H; Shao ZQ; Jiang YD; Wu P; Zhang HJ
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Mar; 25(3):357-9. PubMed ID: 15772014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Laparoscopic versus open partial nephrectomy for the treatment of pathological T1N0M0 renal cell carcinoma: a 5-year survival rate.
    Permpongkosol S; Bagga HS; Romero FR; Sroka M; Jarrett TW; Kavoussi LR
    J Urol; 2006 Nov; 176(5):1984-8; discussion 1988-9. PubMed ID: 17070227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal cell carcinoma in the solitary kidney: an analysis of complications and outcome after nephron sparing surgery.
    Ghavamian R; Cheville JC; Lohse CM; Weaver AL; Zincke H; Blute ML
    J Urol; 2002 Aug; 168(2):454-9. PubMed ID: 12131287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Chromophobe renal cell carcinoma: a clinicopathologic study and immunophenotypes of 42 cases].
    Zhang W; Yu WJ; Jiang YX; Li YJ; Han F; Liu Y; Han ZL
    Zhonghua Bing Li Xue Za Zhi; 2012 Feb; 41(2):76-80. PubMed ID: 22455881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elective nephron sparing surgery for renal cell carcinoma larger than 4 cm.
    Pahernik S; Roos F; Röhrig B; Wiesner C; Thüroff JW
    J Urol; 2008 Jan; 179(1):71-4; discussion 74. PubMed ID: 17997423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Retroperitoneal laparoscopic radical nephrectomy in the treatment of renal cancer].
    Xue Z; He XZ; Cui L; Xu RF; Xu XL
    Zhonghua Zhong Liu Za Zhi; 2011 Aug; 33(8):632-4. PubMed ID: 22325228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal cell carcinoma with renal vein and inferior vena caval involvement: clinicopathological features, surgical techniques and outcomes.
    Parekh DJ; Cookson MS; Chapman W; Harrell F; Wells N; Chang SS; Smith JA
    J Urol; 2005 Jun; 173(6):1897-902. PubMed ID: 15879771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chromophobe renal cell carcinoma: analysis of 61 cases.
    Peyromaure M; Misrai V; Thiounn N; Vieillefond A; Zerbib M; Flam TA; Debré B
    Cancer; 2004 Apr; 100(7):1406-10. PubMed ID: 15042674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chromophobe renal cell carcinoma with sarcomatoid differentiation: a clinicopathologic study of 14 cases.
    Lauer SR; Zhou M; Master VA; Osunkoya AO
    Anal Quant Cytopathol Histpathol; 2013 Apr; 35(2):77-84. PubMed ID: 23700716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A case of chromophobe cell renal carcinoma].
    Ashida S; Yamamoto A; Fukumori T; Yuasa K; Terao N; Iwata J
    Hinyokika Kiyo; 1997 Nov; 43(11):777-80. PubMed ID: 9436020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diagnosis and treatment of pancreatic metastasis from renal cell carcinoma].
    Chi TY; Sang XT; Mao YL; Yang ZY; Lu X; Zhong SX; Huang JF
    Zhonghua Zhong Liu Za Zhi; 2008 Oct; 30(10):793-6. PubMed ID: 19173818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.